Your browser doesn't support javascript.
loading
Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting.
Anttila, Vesa; Saraste, Antti; Knuuti, Juhani; Hedman, Marja; Jaakkola, Pekka; Laugwitz, Karl-Ludwig; Krane, Markus; Jeppsson, Anders; Sillanmäki, Saara; Rosenmeier, Jaya; Zingmark, Pernilla; Rudvik, Anna; Garkaviy, Pavlo; Watson, Christina; Pangalos, Menelas N; Chien, Kenneth R; Fritsche-Danielson, Regina; Collén, Anna; Gan, Li-Ming.
Afiliação
  • Anttila V; Heart Centre, Turku University Hospital and University of Turku, Turku, Finland.
  • Saraste A; Heart Centre, Turku University Hospital and University of Turku, Turku, Finland; Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland.
  • Knuuti J; Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland.
  • Hedman M; Heart Centre, Kuopio University Hospital, Kuopio, Finland; Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
  • Jaakkola P; Heart Centre, Kuopio University Hospital, Kuopio, Finland.
  • Laugwitz KL; First Medical Department (Cardiology, Angiology and Pneumology), Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Krane M; German Centre for Cardiovascular Research (DZHK), Munich Heart Alliance, Munich, Germany; Department of Cardiovascular Surgery, German Heart Centre Munich, Technical University of Munich, Munich, Germany; Division of Cardiac Surgery, Yale School of Medicine, Yale University, New Haven, CT, USA.
  • Jeppsson A; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Sillanmäki S; Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital, Kuopio, Finland.
  • Rosenmeier J; Research and Early Clinical Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Zingmark P; Research and Early Clinical Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Rudvik A; Early Biometrics & Statistical Innovation, Data Science & Artificial Intelligence, R&D, AstraZeneca, Gothenburg, Sweden.
  • Garkaviy P; Research and Early Clinical Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Watson C; Study Management Early, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Pangalos MN; BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, UK.
  • Chien KR; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
  • Fritsche-Danielson R; Research and Early Clinical Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Collén A; Research and Early Clinical Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. Electronic address: anna.collen@astrazeneca.com.
  • Gan LM; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Research and Early Clinical Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Department of Cardiolog
Mol Ther ; 31(3): 866-874, 2023 03 01.
Article em En | MEDLINE | ID: mdl-36528793
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Isquemia Miocárdica / Fator A de Crescimento do Endotélio Vascular Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Finlândia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Isquemia Miocárdica / Fator A de Crescimento do Endotélio Vascular Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Finlândia